0000899243-23-002910.txt : 20230127 0000899243-23-002910.hdr.sgml : 20230127 20230127205023 ACCESSION NUMBER: 0000899243-23-002910 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230118 FILED AS OF DATE: 20230127 DATE AS OF CHANGE: 20230127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Binder Gwendolyn CENTRAL INDEX KEY: 0001791742 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39103 FILM NUMBER: 23564979 MAIL ADDRESS: STREET 1: C/O CABALETTA BIO, INC. STREET 2: 2929 ARCH STREET, SUITE 600 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cabaletta Bio, Inc. CENTRAL INDEX KEY: 0001759138 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 ARCH STREET STREET 2: SUITE 600 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: (267) 759-3100 MAIL ADDRESS: STREET 1: 2929 ARCH STREET STREET 2: SUITE 600 CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-18 0 0001759138 Cabaletta Bio, Inc. CABA 0001791742 Binder Gwendolyn C/O CABALETTA BIO, INC. 2929 ARCH STREET, SUITE 600 PHILADELPHIA PA 19104 0 1 0 0 See Remarks Stock Option (Right to Buy) 11.09 2023-01-18 4 A 0 176000 0.00 A 2033-01-17 Common Stock 176000 176000 D 25% of the shares underlying this option shall vest and become exercisable on January 18, 2024, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date. President, Science & Technology By: /s/ Michael Gerard, as Attorney-in-Fact 2023-01-27